How analytical techniques evolve and support biopharmaceutical drug development?

Roundtable discussion with Amgen

09/28/2021

sponsored by Amgen, Thermo Fisher Scientific

28th September 2021 at 3pm BST

Bringing a new biotherapeutic to market is a multifaceted process. Ensuring safety, efficacy, and product quality is paramount. Biopharmaceuticals, by their nature, are highly complex.

Heterogeneity occurs naturally by biological modification or can be unwanted consequence of manufacturing and storage. Critical quality attributes affecting safety and efficacy need to be identified, characterized, controlled, and monitored throughout the drug discovery and development cycle. Analytical techniques that can characterize and quantify levels of biotherapeutic complexity are in high demand.

Join the conversation as a panel of Amgen experts discuss how analytical techniques evolved over the years to serve the needs of the industry, and what trends they observe which will increase productivity further.

Learning Objectives:

Why is analytical work so important for the discovery, development, and manufacture of new biologic drugs?
What analytical advances have had the biggest impact in terms of developing biologics?
How is Amgen adopting and evaluating new analytical techniques?

Visit our Webinar Hub

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.